文献速递系统性红斑狼疮

IgM抗磷酸胆碱抗体与SLE患者促炎脂质谱中的衰老及IL-17+ T细胞相关

IgM anti-phosphorylcholine antibodies associate with senescent and IL-17+ T cells in SLE patients with a pro-inflammatory lipid profile.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

在197例SLE患者和99例对照中,IgM抗PC抗体水平降低并与年龄、HDL、LDL及糖皮质激素治疗相关;在120例SLE患者和33例对照亚组中,CD4+CD28null和Th17细胞增加且与IgM抗PC抗体负相关,该关联见于高甘油三酯或低HDL患者。

要点

  • SLE患者IgM抗PC抗体降低,与心血管疾病及促动脉粥样硬化T细胞相关。
  • 高甘油三酯或低HDL脂质谱可能促进IgM抗PC与衰老/Th17 T细胞的关联。
  • IgM抗PC抗体与脂质谱的关联提示其心脏保护作用可能受脂质环境影响。

核心结论

  • IgM抗PC抗体与SLE中促动脉粥样硬化T细胞亚群相关,高甘油三酯/低HDL脂质谱起主要促进作用。

研究设计与样本

  • 在197例SLE患者和99例对照中ELISA定量抗PC抗体,并在120例SLE患者和33例对照亚组中行流式细胞术和免疫分析。

主要发现

  • SLE患者IgM抗PC血清水平低于对照(P < 0.001),且与年龄(β= -0.252; P = 0.002)、HDL(β = 0.271; P = 0.001)、LDL(β= -0.192; P = 0.017)及糖皮质激素治疗(β= -0.201; P = 0.012)相关。
  • IgG与IgM抗PC比值升高(P = 0.007),与年龄(β = 0.194; P = 0.028)和SLEDAI(β = 0.250; P = 0.005)相关。
  • 有临床或亚临床心血管疾病的患者IgM抗PC水平低于无心血管疾病者(P = 0.001),不受糖皮质激素使用影响。
  • SLE患者CD4+CD28null和Th17细胞增加(P < 0.01),与IgM抗PC水平负相关;在高甘油三酯或低HDL患者中调整临床参数和治疗后仍显著(CD4+CD28null: β = -0.455, P = 0.001; Th17: β= -0.280, P = 0.035),正常脂质谱者无此关联。

临床怎么用

  • SLE患者监测IgM抗PC抗体及脂质谱可能有助于评估促动脉粥样硬化免疫状态。
  • 对高甘油三酯或低HDL的SLE患者,需关注衰老及Th17 T细胞相关心血管风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim was to evaluate whether T cell subsets and the lipid profile could be linked to the cardioprotective effect of IgM anti-phosphorylcholine (PC) antibodies in SLE. METHODS: Anti-PC antibodies were quantified by ELISA in 197 patients and 99 controls and analysed in relationship to clinical features, treatments and serum lipids. Carotid atheromatosis was evaluated by ultrasonography; Th1, Th17, Treg and CD4+CD28null cells by flow cytometry; and cytokine serum levels by immunoassays, in a subgroup of 120 SLE patients and 33 controls. RESULTS: IgM anti-PC serum levels were reduced in SLE patients compared with controls (P < 0.001) and were associated with age (β= -0.252; P = 0.002), high-density lipoprotein (HDL; β = 0.271; P = 0.001), low-density lipoprotein (LDL; β= -0.192; P = 0.017) and glucocorticoid treatment (β= -0.201; P = 0.012), whereas the IgG-to-IgM anti-PC ratio was increased (P = 0.007) and associated with age (β = 0.194; P = 0.028) and SLEDAI (β = 0.250; P = 0.005). Also, patients with clinical or subclinical cardiovascular disease exhibited reduced IgM anti-PC levels compared with their cardiovascular disease-free counterparts, regardless of glucocorticoid usage (P = 0.001). CD4+CD28null and Th17 cells were increased in SLE patients compared with controls (P < 0.01) and correlated inversely with IgM anti-PC levels. These associations were observed in patients displaying high triglyceride or low HDL levels, even after adjusting for clinical parameters and treatments (CD4+CD28null: β = -0.455, P = 0.001; Th17: β= -0.280, P = 0.035), but not in those with a normal lipid profile. High triglyceride and low HDL profiles were related to low IgM anti-PC and Treg levels, respectively, whereas both lipid profiles were associated with inflammatory markers and cytokines. CONCLUSION: The present study provides evidence for an association of IgM anti-PC antibodies with pro-atherogenic T cell subsets in SLE, with a high triglyceride/low HDL lipid profile playing a facilitating major role.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. López P, Rodríguez-Carrio J, Martínez-Zapico A, et al. IgM anti-phosphorylcholine antibodies associate with senescent and IL-17+ T cells in SLE patients with a pro-inflammatory lipid profile. Rheumatology (Oxford). 2020. PMID: 31302689. doi:10.1093/rheumatology/kez264

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。